Biochemical studies of cerebral sub-fractions after chronic administration of pyridazine (n-morpholine 3-ethylamine 4-phenyl 6-pyridazine hydrochloride, AG 620).
D000110:Acetylcholinesterase / Q000378:metabolism; D000251:Adenosine Triphosphatases / Q000378:metabolism; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002458:Cell Fractionation; D002499:Centrifugation, Density Gradient; D002540:Cerebral Cortex / Q000166:cytology / Q000201:enzymology / Q000378:metabolism*; D005260:Female; D066298:In Vitro Techniques; D008297:Male; D008861:Microsomes / Q000378:metabolism; D009025:Morpholines / Q000494:pharmacology*; D009929:Organ Size; D010710:Phosphates / Q000378:metabolism; D011188:Potassium; D011506:Proteins / Q000378:metabolism; D011724:Pyridazines / Q000494:pharmacology*; D012313:RNA / Q000378:metabolism; D051381:Rats; D012270:Ribosomes / Q000378:metabolism; D012964:Sodium; D013395:Sucrose; D013997:Time Factors
D009025:Morpholines; D010710:Phosphates; D011506:Proteins; D011724:Pyridazines; D013395:Sucrose; D012313:RNA; D012964:Sodium; D000110:Acetylcholinesterase; D000251:Adenosine Triphosphatases; D011188:Potassium